In vitro tumor necrosis factor cytotoxicity in HEP G2 liver cells

Hepatology

Volumn 21, Issue 4, 1995, Pages 1114-1119

  Hill, Daniell B ^a   Schmidt, Jack ^a   Shedlofsky, Steven I ^a   Cohen, Donald A ^a   McClain, Craig J ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; RECOMBINANT TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DOSE RESPONSE; FEVER; FIBROBLAST; HEP 2 CELL; HEPATOBLASTOMA; HUMAN; HUMAN CELL; LIVER CELL DAMAGE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TEMPERATURE SENSITIVITY; TUMOR CELL LINE;

CELL SURVIVAL; HUMAN; LIVER; PROTEINS; RNA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TEMPERATURE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR;

EID: 0028920116     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1016/0270-9139(95)90263-5     Document Type: Article

References (46)

1. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholics
2. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice
3. Involvement of tumor necrosis factor-a in development of hepatic injury in galactosamine-sensitized mice
4. Involvement of tumor necrosis factor-a in the pathogenesis of activated macrophage-mediated hepatitis in mice
5. Enhanced tumor necrosis factor and interleukin-1 in an experimental model of massive liver cell necrosis/fatal hepatitis in mice
6. Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat
7. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure
8. Does tumor necrosis factor play a role in the pathogenesis of fulminant hepatitis?
9. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis
10. Tumor necrosis factor, the acute phase response and the pathogenesis of alcoholic liver disease
11. Increased plasma tumor necrosis factor in severe alcoholic hepatitis
12. Plasma tumor necrosis factor a predicts decreased long-term survival in severe alcoholic hepatitis
13. Cytokines and alcoholic liver disease
14. Hep G2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids
15. Microsomal induction, alcohol, and lipoprotein metabolism: is there a three-way relationship?
16. Regulation of squalene synthetase in human hepatoma cell line Hep G2 by sterols, and not by mevalonate-derived non-sterols
17. Interleukin 1 and tumour necrosis factor increase phosphorylation of the small heat shock protein
18. 2/B-cell stimulating factor 2/interleukin 6 affects glycosylation of acute phase proteins in human hepatoma cell lines
19. Interleukin-6 enhances the expression of tumor necrosis factor receptors on hepatoma cells and hepatocytes
20. Possible requirement of internalization in the mechanism of in vitro cytotoxicity in tumor necrosis factor serum
21. Rabbit tumor necrosis factor: mechanism of action
22. Tumor necrosis factor-mediated cytotoxicity involves ADP-ribosylation
23. Evidence for two mechanisms by which tumor necrosis factor kills cells
24. Extracellular ATP and adenosine modulate tumor necrosis factor-induced lysis of L929 cells in the presence of actinomycin D
25. Cycloheximide-induced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cells
26. Serum-free in vitro bioassay for the detection of tumor necrosis factor
27. Comparison of in vitro cell cytotoxic assay for tumor necrosis factor
28. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing
29. Protein measurement with a folin phenol reagent
30. Tumor necrosis factor-a produces hepatocellular dysfunction despite normal cardiac output and hepatic microcirculation
31. The acute and chronic pathophysiologic effects of TNF: mediation of septic shock and wasting (cachexia)
32. Toxic effects of recombinant tumor necrosis factor in suckling mice
33. Novel tumor necrosis factor toxic effects
34. Cytostatic and cytotoxic activity of tumor necrosis factor on human cancer cells
35. 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity
36. Rabbit tumor necrosis factor: mechanism of action
37. Comparative in vitro studies of the potentiation of TNF-alpha, TNF-beta, and TNF-sam2 cytotoxicity by hyperthermia
38. Transforming growth factor-β in disease: the dark side of tissue repair
39. Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans
40. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists
41. Regulation of the pathophysiology of tumor necrosis factor
42. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism
43. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor
44. The acute phase response protects mice from D-galactosamine sensitization to endotoxin and tumor necrosis factor-a
45. Cytotoxic mechanism of tumor necrosis factor-a